Therapeutic antibodies and uses thereof

Bradley Walsh (Inventor), Douglas Campbell (Inventor), Sandra Wissmueller (Inventor)

    Research output: Patent


    The present invention relates to therapeutic antibodies for the treatment of cancer, and more specifically, for the treatment of prostate, bladder, and/or pancreatic cancer. An embodiment of the present invention is an anti-glypican-1 (GPC 1) antibody, which may be conjugated to at least one cytotoxic agent that is toxic to a prostate, bladder, and/or pancreatic cancer cell.
    Original languageEnglish
    Patent numberAU2016250900
    IPCC07K 16/28,A61K 39/395,A61P 35/00,C07K 16/30
    Priority date20/04/15
    Filing date20/04/16
    Publication statusSubmitted - 20 Apr 2016


    Dive into the research topics of 'Therapeutic antibodies and uses thereof'. Together they form a unique fingerprint.

    Cite this